Literature DB >> 7836516

Fertility drugs and risk of epithelial ovarian cancer in Italy.

S Franceschi1, C La Vecchia, E Negri, S Guarneri, M Montella, E Conti, F Parazzini.   

Abstract

The report of an increase of ovarian cancer risk among women who had used fertility drugs prompted us to analyse the relationship between fertility drugs and ovarian cancer in a case-control study which has been ongoing in four areas of Italy since 1992. The present analysis is based on 195 epithelial ovarian cancer cases and 1339 controls admitted to hospital for diseases other than gynaecological or malignant conditions. Fewer ovarian cancer cases than controls reported use of fertility drugs (odds ratio, after allowance for potential confounding factors: 0.7, 95% confidence interval: 0.2-3.3). Among nulligravid women, 5/177 control women compared with 0/36 cancer cases reported having ever used fertility drugs. Although only based on small numbers of women who were suffering from ovarian cancer and who had also used fertility drugs, the present study indicated that a role of ovarian stimulation in the aetiology of epithelial ovarian cancer is not established, although it is worth investigating.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836516     DOI: 10.1093/oxfordjournals.humrep.a138771

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

1.  Fertility drugs and ovarian epithelial cancer: is there a link?

Authors:  R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

2.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

3.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

Review 4.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

5.  Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10.

Authors:  Linah F Al-Alem; Lauren A McCord; R Chase Southard; Michael W Kilgore; Thomas E Curry
Journal:  Biol Reprod       Date:  2013-09-27       Impact factor: 4.285

Review 6.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

7.  In vivo evaluation of the genotoxic effects of gonadotropins on rat reticulocytes.

Authors:  Bulent Duran; Onder Koc; Safak Ozdemirci; Ata Topcuoglu; Ozturk Ozdemir
Journal:  Curr Ther Res Clin Exp       Date:  2011-04

8.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

Authors:  F E van Leeuwen; H Klip; T M Mooij; A M G van de Swaluw; C B Lambalk; M Kortman; J S E Laven; C A M Jansen; F M Helmerhorst; B J Cohlen; W N P Willemsen; J M J Smeenk; A H M Simons; F van der Veen; J L H Evers; P A van Dop; N S Macklon; C W Burger
Journal:  Hum Reprod       Date:  2011-10-26       Impact factor: 6.918

9.  Gestational choriocarcinoma diagnosed with spontaneous splenic rupture after pregnancy induced by in vitro fertilization: a case report.

Authors:  Mehmet Yürüyen; Ozcan Yildiz; Cigdem Papila; Nukhet Tuzuner
Journal:  Cases J       Date:  2009-05-15

10.  Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.

Authors:  Allan Jensen; Heidi Sharif; Kirsten Frederiksen; Susanne Krüger Kjaer
Journal:  BMJ       Date:  2009-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.